Cardiovascular mortality risk among small bowel adenocarcinoma patients: a population-based study

Abstract Background The objective of this research is to statistically assess the risk of cardiovascular mortality (CVM) between patients with small bowel adenocarcinoma (SBA) and the general population. Additionally, it aims to identify CVM-associated risk factors among individuals with SBA. Method...

Full description

Saved in:
Bibliographic Details
Main Authors: Yao Zhang, Shicong Zeng, Zongwen Wang, Qiankun Zhu, Jingtao Li, Xiaohang Ren, Shuoheng Ma, Gang Tan, Bo Zhai
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Public Health
Subjects:
Online Access:https://doi.org/10.1186/s12889-025-21279-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544200465678336
author Yao Zhang
Shicong Zeng
Zongwen Wang
Qiankun Zhu
Jingtao Li
Xiaohang Ren
Shuoheng Ma
Gang Tan
Bo Zhai
author_facet Yao Zhang
Shicong Zeng
Zongwen Wang
Qiankun Zhu
Jingtao Li
Xiaohang Ren
Shuoheng Ma
Gang Tan
Bo Zhai
author_sort Yao Zhang
collection DOAJ
description Abstract Background The objective of this research is to statistically assess the risk of cardiovascular mortality (CVM) between patients with small bowel adenocarcinoma (SBA) and the general population. Additionally, it aims to identify CVM-associated risk factors among individuals with SBA. Methods Data obtained between 2000 and 2017 on SBA patients from the Surveillance, Epidemiology, and End Results (SEER) database were examined. Standardized mortality ratios (SMRs) and absolute excess risks (AERs) were obtained to compare CVM between patients and the general US population. To evaluate the cumulative mortality (CM) rate for all causes of death (COD), cumulative hazard curves were constructed. Two multivariate competing risk models were established to determine the independent predictors for CVM. Results In the cohort of 5,175 SBA patients observed for 15,068.24 person-years, a total of 205 deaths were attributed to cardiovascular disease (CVD). The overall SMR of CVM was 1.41 (95% confidence interval (CI): 1.23–1.62, P < 0.05), whereas it reached 2.99 during the early stage of latency. Additionally, independent risk factors for CVM included age, marital status, calendar year of diagnosis, disease differentiation degree, SEER stage, and chemotherapy status. Conclusions SBA patients exhibited a substantially elevated risk of developing CVM compared to the general US population. During the follow-up period, the CM rate for CVM continued to rise steadily. Timely identification of high-risk groups and effective interventions to safeguard cardiovascular health significantly improve patient prognosis.
format Article
id doaj-art-7886a768124a4f27ba2cd15ce50c5ff1
institution Kabale University
issn 1471-2458
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Public Health
spelling doaj-art-7886a768124a4f27ba2cd15ce50c5ff12025-01-12T12:43:15ZengBMCBMC Public Health1471-24582025-01-0125111410.1186/s12889-025-21279-5Cardiovascular mortality risk among small bowel adenocarcinoma patients: a population-based studyYao Zhang0Shicong Zeng1Zongwen Wang2Qiankun Zhu3Jingtao Li4Xiaohang Ren5Shuoheng Ma6Gang Tan7Bo Zhai8Department of General Surgery, The Fourth Affiliated Hospital, Harbin Medical UniversityDepartment of General Surgery, The Fourth Affiliated Hospital, Harbin Medical UniversityDepartment of General Surgery, The Fourth Affiliated Hospital, Harbin Medical UniversityDepartment of Intervention Radiology, The Fourth Affiliated Hospital, Harbin Medical UniversityDepartment of General Surgery, The Fourth Affiliated Hospital, Harbin Medical UniversityDepartment of General Surgery, The Fourth Affiliated Hospital, Harbin Medical UniversityDepartment of General Surgery, The Fourth Affiliated Hospital, Harbin Medical UniversityDepartment of General Surgery, The Fourth Affiliated Hospital, Harbin Medical UniversityDepartment of General Surgery, The Fourth Affiliated Hospital, Harbin Medical UniversityAbstract Background The objective of this research is to statistically assess the risk of cardiovascular mortality (CVM) between patients with small bowel adenocarcinoma (SBA) and the general population. Additionally, it aims to identify CVM-associated risk factors among individuals with SBA. Methods Data obtained between 2000 and 2017 on SBA patients from the Surveillance, Epidemiology, and End Results (SEER) database were examined. Standardized mortality ratios (SMRs) and absolute excess risks (AERs) were obtained to compare CVM between patients and the general US population. To evaluate the cumulative mortality (CM) rate for all causes of death (COD), cumulative hazard curves were constructed. Two multivariate competing risk models were established to determine the independent predictors for CVM. Results In the cohort of 5,175 SBA patients observed for 15,068.24 person-years, a total of 205 deaths were attributed to cardiovascular disease (CVD). The overall SMR of CVM was 1.41 (95% confidence interval (CI): 1.23–1.62, P < 0.05), whereas it reached 2.99 during the early stage of latency. Additionally, independent risk factors for CVM included age, marital status, calendar year of diagnosis, disease differentiation degree, SEER stage, and chemotherapy status. Conclusions SBA patients exhibited a substantially elevated risk of developing CVM compared to the general US population. During the follow-up period, the CM rate for CVM continued to rise steadily. Timely identification of high-risk groups and effective interventions to safeguard cardiovascular health significantly improve patient prognosis.https://doi.org/10.1186/s12889-025-21279-5Small bowel adenocarcinomaClinical cancer researchCardiovascular mortalityEpidemiologyCompeting risk regression
spellingShingle Yao Zhang
Shicong Zeng
Zongwen Wang
Qiankun Zhu
Jingtao Li
Xiaohang Ren
Shuoheng Ma
Gang Tan
Bo Zhai
Cardiovascular mortality risk among small bowel adenocarcinoma patients: a population-based study
BMC Public Health
Small bowel adenocarcinoma
Clinical cancer research
Cardiovascular mortality
Epidemiology
Competing risk regression
title Cardiovascular mortality risk among small bowel adenocarcinoma patients: a population-based study
title_full Cardiovascular mortality risk among small bowel adenocarcinoma patients: a population-based study
title_fullStr Cardiovascular mortality risk among small bowel adenocarcinoma patients: a population-based study
title_full_unstemmed Cardiovascular mortality risk among small bowel adenocarcinoma patients: a population-based study
title_short Cardiovascular mortality risk among small bowel adenocarcinoma patients: a population-based study
title_sort cardiovascular mortality risk among small bowel adenocarcinoma patients a population based study
topic Small bowel adenocarcinoma
Clinical cancer research
Cardiovascular mortality
Epidemiology
Competing risk regression
url https://doi.org/10.1186/s12889-025-21279-5
work_keys_str_mv AT yaozhang cardiovascularmortalityriskamongsmallboweladenocarcinomapatientsapopulationbasedstudy
AT shicongzeng cardiovascularmortalityriskamongsmallboweladenocarcinomapatientsapopulationbasedstudy
AT zongwenwang cardiovascularmortalityriskamongsmallboweladenocarcinomapatientsapopulationbasedstudy
AT qiankunzhu cardiovascularmortalityriskamongsmallboweladenocarcinomapatientsapopulationbasedstudy
AT jingtaoli cardiovascularmortalityriskamongsmallboweladenocarcinomapatientsapopulationbasedstudy
AT xiaohangren cardiovascularmortalityriskamongsmallboweladenocarcinomapatientsapopulationbasedstudy
AT shuohengma cardiovascularmortalityriskamongsmallboweladenocarcinomapatientsapopulationbasedstudy
AT gangtan cardiovascularmortalityriskamongsmallboweladenocarcinomapatientsapopulationbasedstudy
AT bozhai cardiovascularmortalityriskamongsmallboweladenocarcinomapatientsapopulationbasedstudy